These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 33257091)
21. The effects of long-term administration of oral desmopressin on the baseline secretion of antidiuretic hormone and serum sodium concentration for the treatment of nocturia: a circadian study. Bae JH; Oh MM; Shim KS; Cheon J; Lee JG; Kim JJ; Moon DG J Urol; 2007 Jul; 178(1):200-3. PubMed ID: 17499799 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and Safety of Desmopressin Add-On Therapy for Men with Persistent Nocturia on α-Blocker Monotherapy for Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo Controlled Study. Kim JC; Cho KJ; Lee JG; Seo JT; Kim DY; Oh SJ; Lee KS; Choo MS; Lee JZ J Urol; 2017 Feb; 197(2):459-464. PubMed ID: 27622611 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of desmopressin for treatment of nocturia: a systematic review and meta-analysis of double-blinded trials. Zong H; Yang C; Peng X; Zhang Y Int Urol Nephrol; 2012 Apr; 44(2):377-84. PubMed ID: 21898039 [TBL] [Abstract][Full Text] [Related]
24. Desmopressin and the risk of hyponatremia: A population-based cohort study. Fralick M; Schneeweiss S; Wallis CJD; Jung EH; Kesselheim AS PLoS Med; 2019 Oct; 16(10):e1002930. PubMed ID: 31634354 [TBL] [Abstract][Full Text] [Related]
25. Use of desmopressin in elderly patients in Denmark. Callréus T Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):995-8. PubMed ID: 17437326 [TBL] [Abstract][Full Text] [Related]
26. Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial. Yamaguchi O; Nishizawa O; Juul KV; Nørgaard JP BJU Int; 2013 Mar; 111(3):474-84. PubMed ID: 23046147 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and Safety of SER120 Nasal Spray in Patients with Nocturia: Pooled Analysis of 2 Randomized, Double-Blind, Placebo Controlled, Phase 3 Trials. Kaminetsky J; Fein S; Dmochowski R; MacDiarmid S; Abrams S; Cheng M; Wein A J Urol; 2018 Sep; 200(3):604-611. PubMed ID: 29654805 [TBL] [Abstract][Full Text] [Related]
28. Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues. Van de Walle J; Van Herzeele C; Raes A Drug Saf; 2010 Apr; 33(4):261-71. PubMed ID: 20297859 [TBL] [Abstract][Full Text] [Related]
29. Maximal bladder capacity is a positive predictor of response to desmopressin treatment in patients with MS and nocturia. Zahariou A; Karamouti M; Karagiannis G; Papaioannou P Int Urol Nephrol; 2008; 40(1):65-9. PubMed ID: 17610036 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of desmopressin in nocturia and nocturnal polyuria control of neurological patients: A systematic review and meta-analysis. Hajebrahimi S; Darvishi A; HajEbrahimi R; Asadi N; Jafari Shendi Z; Asiaban N; Naseri A; Sadeghi-Ghyassi F; Mostafaei H; Salehi-Pourmehr H Neurourol Urodyn; 2024 Jan; 43(1):167-182. PubMed ID: 37746880 [TBL] [Abstract][Full Text] [Related]
32. [Treatment of nocturia in men with desmopressin]. Mühlstädt S Urologe A; 2018 Apr; 57(4):458-462. PubMed ID: 29492635 [No Abstract] [Full Text] [Related]
33. Re: Safety and Efficacy of Desmopressin for the Treatment of Nocturia in Elderly Patients: A Cohort Study. Griebling TL J Urol; 2015 Sep; 194(3):732. PubMed ID: 26292871 [No Abstract] [Full Text] [Related]
34. Desmopressin acetate the first sublingual tablet to treat nocturia due to nocturnal polyuria. Alford N; Hashim H Expert Rev Clin Pharmacol; 2021 Aug; 14(8):939-954. PubMed ID: 33993824 [No Abstract] [Full Text] [Related]
35. Re: A systematic review of the efficacy and safety of desmopressin for nocturia in adults: M. H. Ebell, T. Radke and J. Gardner J Urol 2014;192:829-835. Nørgaard JP; Juul KV; Gupta J J Urol; 2015 May; 193(5):1729; discussion 1730. PubMed ID: 25660473 [No Abstract] [Full Text] [Related]
36. Efficacy and safety of desmopressin in women with nocturia: a systematic review and meta-analysis of randomized controlled trials. Cai X; Tian Y; Nie M; Wang K Int Urol Nephrol; 2019 Nov; 51(11):1913-1923. PubMed ID: 31352583 [TBL] [Abstract][Full Text] [Related]
37. Desmopressin 30 years in clinical use: a safety review. Vande Walle J; Stockner M; Raes A; Nørgaard JP Curr Drug Saf; 2007 Sep; 2(3):232-8. PubMed ID: 18690973 [TBL] [Abstract][Full Text] [Related]
38. The relationship between the action of arginine vasopressin and responsiveness to oral desmopressin in older men: a pilot study. Johnson TM; Burridge A; Issa MM; Miller M; Tang T; Ouslander JG J Am Geriatr Soc; 2007 Apr; 55(4):562-9. PubMed ID: 17397435 [TBL] [Abstract][Full Text] [Related]
39. Comparison of nocturia response to desmopressin treatment between patients with normal and high nocturnal bladder capacity index. Hajdinjak T; Leskovar J ScientificWorldJournal; 2013; 2013():878564. PubMed ID: 24223034 [TBL] [Abstract][Full Text] [Related]
40. An overview of nocturia and the syndrome of nocturnal polyuria in the elderly. Kujubu DA; Aboseif SR Nat Clin Pract Nephrol; 2008 Aug; 4(8):426-35. PubMed ID: 18578009 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]